Literature DB >> 12739745

Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella.

G Osella1, F Orlandi, P Caraci, M Ventura, D Deandreis, M Papotti, M Bongiovanni, A Angeli, M Terzolo.   

Abstract

GH hyperproduction due to ectopic secretion of GHRH is a rare cause of acromegaly. Since 1959, approximately 50 cases of ectopic GHRH production from extrapituitary tumors have been described. Here we report the clinical and biochemical features of a 47-yr-old Caucasian woman with ectopic GHRH syndrome sustained by a bronchial carcinoid. The criteria for the diagnosis of acromegaly due to ectopic GHRH secretion were satisfied in our patient (i.e. confirmation of active GH hypersecretion, unequivocal demonstration of GHRH production and secretion from an extrapituitary tumor and cure of acromegaly after neoplasm removal). The tumor was an atypical carcinoid and there was a familial history of lung and colorectal cancer. Acromegaly was slightly active (mean GH value: 7.4 ng/ml, IGF-I: 436 ng/ml) and after tumor removal there was a progressive decline of GH levels, consistent with remission of pituitary somatotroph hyperplasia. Pituitary radiology showed an empty sella demonstrating for the first time its association with ectopic GHRH syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739745     DOI: 10.1007/BF03345146

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor.

Authors:  A Van den Bruel; J Fevery; J Van Dorpe; L Hofland; R Bouillon
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

2.  Post-incubation heating significantly improves tyramide signal amplification.

Authors:  M Volante; C Pecchioni; G Bussolati
Journal:  J Histochem Cytochem       Date:  2000-11       Impact factor: 2.479

Review 3.  111In-octreotide scintigraphy in oncology.

Authors:  E P Krenning; D J Kwekkeboom; J C Reubi; P M Van Hagen; C H van Eijck; H Y Oei; S W Lamberts
Journal:  Metabolism       Date:  1992-09       Impact factor: 8.694

4.  [On a bronchus carcinoid containing bone (morphological and clinical observations in an acromegalic patient)].

Authors:  H W ALTMANN; W SCHUETZ
Journal:  Beitr Pathol Anat       Date:  1959

Review 5.  Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome.

Authors:  M Losa; K von Werder
Journal:  Clin Endocrinol (Oxf)       Date:  1997-08       Impact factor: 3.478

6.  Ectopic acromegaly.

Authors:  J K Platts; D F Child; P Meadows; J N Harvey
Journal:  Postgrad Med J       Date:  1997-06       Impact factor: 2.401

Review 7.  Somatostatin receptor subtype expression in human tumors.

Authors:  L J Hofland; S W Lamberts
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

8.  Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.

Authors:  N Ling; F Esch; P Böhlen; P Brazeau; W B Wehrenberg; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

Review 9.  Current treatment guidelines for acromegaly.

Authors:  S Melmed; I Jackson; D Kleinberg; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

Review 10.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871

View more
  5 in total

1.  Acromegaly: disease or syndrome? Not only a semantic question.

Authors:  Giovanni Faglia
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

Review 2.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 3.  Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review.

Authors:  Iga Zendran; Gabriela Gut; Marcin Kałużny; Katarzyna Zawadzka; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 4.  Ectopic acromegaly due to growth hormone releasing hormone.

Authors:  Ali A Ghazi; Alireza Amirbaigloo; Azizollah Abbasi Dezfooli; Navid Saadat; Siavash Ghazi; Marina Pourafkari; Farrokh Tirgari; Dheepti Dhall; Serguei Bannykh; Shlomo Melmed; Odelia Cooper
Journal:  Endocrine       Date:  2012-09-15       Impact factor: 3.633

5.  Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.

Authors:  Nienke R Biermasz; Jan W A Smit; Alberto M Pereira; Marijke Frölich; Johannes A Romijn; Ferdinand Roelfsema
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.